Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nomenclature and definition of hepatic encephalopathy - An update.

Clinical liver disease·2019

Same author

Understanding the impact of neurologic complications in patients with cirrhosis.

SAGE open medicine·2019

Same author

Rifaximin has the potential to prevent complications of cirrhosis.

Therapeutic advances in gastroenterology·2018

Same author

Practical Issues in the Management of Overt Hepatic Encephalopathy.

Gastroenterology & hepatology·2017

Same author

A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.

Digestive diseases and sciences·2017

Same author

Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.

Digestive diseases and sciences·2017

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Real-Time Dynamic Collection of Hippocampal Extracellular Fluid from Conscious Rats Using a Microdialysis System

Real-Time Dynamic Collection of Hippocampal Extracellular Fluid from Conscious Rats Using a Microdialysis System

Published on: October 21, 2022

Minimal hepatic encephalopathy: simplifying its diagnosis.

Satish Iduru, Kola Hisamuddin, Kevin D Mullen

The American Journal of Gastroenterology

|June 27, 2007

Summary

Minimal hepatic encephalopathy (MHE), a common cirrhosis complication affecting quality of life, can be diagnosed using inhibitory control testing (ICT). This reliable screening tool is easily administered, showing potential for widespread clinical use.

More Related Videos

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Related Experiment Videos

Last Updated: Jul 14, 2026

Real-Time Dynamic Collection of Hippocampal Extracellular Fluid from Conscious Rats Using a Microdialysis System

Real-Time Dynamic Collection of Hippocampal Extracellular Fluid from Conscious Rats Using a Microdialysis System

Published on: October 21, 2022

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Area of Science:

Hepatology
Neurology
Clinical Diagnostics

Background:

Minimal hepatic encephalopathy (MHE) significantly impacts the quality of life for patients with cirrhosis.
Clinical diagnosis of MHE is often challenging due to subtle symptoms.
Inhibitory control testing (ICT) is an established screening method for MHE.

Discussion:

The study validates ICT as a simple, reliable screening tool for MHE.
ICT can be effectively administered by ancillary clinical staff.
The findings suggest ICT's potential for widespread adoption in diagnosing MHE.

Key Insights:

Inhibitory control testing (ICT) demonstrates high reliability and ease of use for MHE screening.
Ancillary staff can be trained to administer ICT, improving clinic efficiency.
ICT shows promise as a popular diagnostic tool for MHE in cirrhosis patients.

Outlook:

Further multicenter studies are recommended to validate ICT for broader clinical application.
Wider validation could establish ICT as a standard diagnostic tool for all cirrhosis patients.
The integration of ICT into routine clinical practice could improve MHE detection rates.